These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20643762)
1. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial. Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L; Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762 [TBL] [Abstract][Full Text] [Related]
2. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L; N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574 [TBL] [Abstract][Full Text] [Related]
3. [Wegener's granulomatosis and microscopic polyangiitis]. Pagnoux C Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109 [TBL] [Abstract][Full Text] [Related]
4. Etanercept plus standard therapy for Wegener's granulomatosis. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801 [TBL] [Abstract][Full Text] [Related]
5. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment. Lynch JP; Tazelaar H Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414 [TBL] [Abstract][Full Text] [Related]
6. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients]. Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553 [TBL] [Abstract][Full Text] [Related]
7. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients. Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L; Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268 [TBL] [Abstract][Full Text] [Related]
8. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Langford CA; Talar-Williams C; Barron KS; Sneller MC Arthritis Rheum; 1999 Dec; 42(12):2666-73. PubMed ID: 10616016 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of microscopic polyangiitis, 17-year experience at a single center. Borao-Cengotita-Bengoa M; Corral-Gudino L; Del Pino-Montes J; Lerma-Márquez JL Eur J Intern Med; 2010 Dec; 21(6):542-7. PubMed ID: 21111941 [TBL] [Abstract][Full Text] [Related]
10. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?]. Reinhold-Keller E Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791 [No Abstract] [Full Text] [Related]
11. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. Koldingsnes W; Nossent JC J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394 [TBL] [Abstract][Full Text] [Related]
12. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864 [TBL] [Abstract][Full Text] [Related]
13. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E; Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271 [TBL] [Abstract][Full Text] [Related]
14. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis. Semple D; Keogh J; Forni L; Venn R Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077 [TBL] [Abstract][Full Text] [Related]
15. Role of plasmapheresis performed in hemodialysis units for the treatment of anti-neutrophilic cytoplasmic antibody-associated systemic vasculitides. Aydin Z; Gursu M; Karadag S; Uzun S; Tatli E; Sumnu A; Ozturk S; Kazancioglu R Ther Apher Dial; 2011 Oct; 15(5):493-8. PubMed ID: 21974704 [TBL] [Abstract][Full Text] [Related]
16. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties. Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161 [TBL] [Abstract][Full Text] [Related]
17. Delayed presentation of Wegener's granulomatosis with pancreatic involvement. Hamilton L; Gaffney K; Andreou A; Saada J Int J Rheum Dis; 2011 Oct; 14(4):e54-5. PubMed ID: 22004241 [No Abstract] [Full Text] [Related]
19. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H; Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413 [TBL] [Abstract][Full Text] [Related]
20. Control of a relapse and induction of long-term remission of Wegener's granulomatosis by cyclosporine. Ghez D; Westeel PF; Henry I; Pruna A; Fournier A; Lassoued K Am J Kidney Dis; 2002 Aug; 40(2):E6. PubMed ID: 12148127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]